Advent Life Sciences — 2018 Investments
2 investments dated 2018 · listed companies and verified rows first · show all
Emergent BioSolutions is a public health company that develops, manufactures, and supplies medical countermeasures for national security and preparedness, along with commercialized products addressing threats such as the opioid epidemic.
Advanced ManufacturingBiotechHealthtechGaithersburg, US
Fuad El-Hibri(Director, Executive Officer)Robert G Kramer(Executive Officer)Katherine Strei(Executive Officer)Adam R Havey(Executive Officer)Daniel J Abdun-Nabi(Executive Officer, Director)Zsolt Harsanyi(Director)
Co-investorsOrbiMed
BiotechWatertown, US
Edward Mascioli(Executive Officer)Andrew Myers(Director)
BoardMarkus Goebel(Director)Henry Skinner(Director)Vikas Goyal(Director)
Board seatRaj Parekh· per SEC Form D · $20M raise · filed Mar 2018
Co-investorsRoche Venture Fund
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.